National Health Investors Stock Price, News & Analysis

National Health Investors (NYSE:NHI) has announced its third quarter dividend payment for 2025. The company will distribute a dividend of $0.92 per common share to stockholders. The dividend will be paid on October 31, 2025, to shareholders of record as of September 30, 2025.

National Health Investors (NYSE:NHI) reported strong Q2 2025 results, exceeding expectations and leading to raised full-year guidance. The company achieved normalized FFO of $1.22 per diluted share, up from $1.18 in Q2 2024. Key highlights include:

The company completed significant portfolio changes, including the $63.5 million acquisition of six memory care communities and the transition of seven properties to their SHOP portfolio. Rental income increased 6.9% to $4.5 million, driven by new investments since June 2024.

NHI maintains a strong financial position with $1.1 billion in net debt and a favorable net debt to adjusted EBITDA ratio of 3.9x. The company updated its 2025 guidance, projecting normalized FFO per share of $4.78-$4.82 and normalized FAD of $227.9-$229.8 million.

National Health Investors (NYSE:NHI) has scheduled its second quarter 2025 earnings release and conference call. The company will release Q2 2025 financial results after market close on Wednesday, August 6, 2025.

A conference call to discuss the results will be held on Thursday, August 7, 2025, at 10:00 a.m. Eastern Time. Investors can participate via interactive teleconference at (888) 506-0062 using access code 494218. The call will also be available via live webcast on the company's website and will remain accessible for replay for one year.

Land & Buildings Investment Management issued a critical analysis of National Healthcare Corp's (NHC) lease negotiation with National Health Investors (NHI), which expires in 2026. The investment firm, which holds a short position in NHC, outlines three potential scenarios for NHC, all potentially negative. The best-case scenario could see NHC losing 19% of EBITDA with fair market rent negotiations, while the worst case could result in a 38% EBITDA loss if NHI leases to another operator. The analysis criticizes the historically below-market lease terms orchestrated by the Adams brothers, who ran both companies. Recent developments, including Robert Adams' narrow board reelection victory, suggest NHI now has leverage in negotiations. Land & Buildings warns that aggressive negotiation tactics by NHC could risk regulatory scrutiny and significant shareholder value destruction.

National Health Investors (NYSE:NHI) released an investor update presentation highlighting its investment pipeline developments. The healthcare REIT reported a total investment pipeline of $331.4 million, which includes $126.7 million in signed Letters of Intent (LOIs). Notably, approximately $71 million of the LOIs is allocated for a SHOP (Senior Housing Operating Portfolio) investment, indicating the company's continued focus on expanding its senior housing segment.

Land & Buildings Investment Management, a significant stockholder of National Health Investors (NYSE: NHI), narrowly missed securing a board seat at NHI's 2025 Annual Meeting, falling short by approximately 1% of outstanding shares. Despite the loss, their nominees received substantial support from about 60% of unaffiliated stockholders who voted. The activist investor acknowledged improvements made by NHI in response to their engagement but maintains that further changes are needed. Land & Buildings will continue monitoring NHI's governance, particularly focusing on the upcoming NHC lease renewal negotiation and capital allocation decisions, and threatens potential future stockholder actions if necessary.

National Health Investors (NYSE:NHI) announced the preliminary results of its 2025 Annual Meeting of Stockholders, where shareholders elected all four of the company's director nominees: Robert G. Adams, Robert W. Chapin, Jr., James R. Jobe, and Candice W. Todd. The company acknowledged the constructive dialogue with stockholders and highlighted recent corporate governance improvements, including the declassification of its Board. NHI expressed confidence in its strategy to generate superior total shareholder return while recognizing the need for continued improvements. The company has retained Hogan Lovells US LLP as legal counsel and Sodali & Co. as proxy solicitor. Final voting results will be filed with the SEC on Form 8-K.

NHI (NYSE:NHI) has issued a response to ISS's recent recommendation regarding board nominations. The company strongly disagrees with ISS's recommendation to support Land & Buildings nominees, arguing it could disrupt NHI's momentum in the senior housing industry. NHI emphasizes their superior total shareholder return (TSR) and operational performance, including over $400 million in dispositions of underperforming assets during the pandemic. The company highlights that current nominees Robert G. Adams and James R. Jobe possess critical industry experience, while L&B's nominees lack relevant operational experience. NHI points to recent governance improvements, including adding 5 new independent directors in 5 years and forming a Special Committee for NHC lease negotiations. The company urges shareholders to vote "FOR" NHI's director nominees on the WHITE proxy card at the upcoming May 21, 2025 Annual Meeting.

National Health Investors (NYSE: NHI) announced on May 5, 2025 that it has released an investor update, which can be accessed through their investor relations website. The update is available at https://investors.nhireit.com/News/presentations-and-webcasts/default.aspx. No specific details about the contents of the update were provided in the press release.